Hallucinations in Parkinson's disease: A follow‐up study
The DOI matches its Crossref record.
Abstract
To study prevalence of hallucinations in patients with Parkinson's disease (PD) during a 1‐year period, and identify factors predictive of the onset of hallucinations in patients who were hallucination‐free at baseline, 141 unselected outpatients with PD were evaluated prospectively for a set of demographic, clinical, and therapeutic variables and the presence of hallucinations during the previous 3 months. Patient groups were compared with nonparametric tests, and logistic regression was applied to significant data. Follow‐up data were available for 127 patients. The hallucination prevalence rates (%) at the first and second evaluation were, respectively, 41.7 and 49.6 for hallucinations of all types (NS), 29.1 and 40.2 for minor hallucinations (i.e., presence or passage hallucinations, and illusions) (P = 0.02), 22.8 and 21.2 for formed visual hallucinations (NS), and 8.7 and 8.7 for auditory hallucinations (NS). Hallucinations rarely started or ceased during the study. The most labile forms were minor hallucinations, which developed in 20% of patients and ceased in 9%. During follow‐up, 15% of patients started to hallucinate. Three factors, all present at the first evaluation, independently predicted the onset of hallucinations in patients previously free of hallucinations at baseline (odds ratio; 95% confidence interval): severe sleep disturbances (14.3; 2.5–80.9), ocular disorders (9.1; 1.6–52.0), and a high axial motor score (5.7; 1.2–27.4). Hallucinations have a chronic course in most parkinsonian patients. Factors predicting the onset of hallucinations point to a role of extranigral brainstem involvement and a nonspecific, facilitating role of ocular disorders. © 2004 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Neuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 557
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21382 · Cited by 528
A 12-Year Population-Based Study of Psychosis in Parkinson Disease
Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T., Goetz, C. G., Stebbins, G. T., Aarsland, D., & Alves, G. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.166 · Cited by 394
Epidemiology of Parkinson’s disease
Alves, G., Forsaa, E. B., Pedersen, K. F., Dreetz Gjerstad, M., & Larsen, J. P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5004-3 · Cited by 363
Epidemiology of psychosis in Parkinson's disease
Fénelon, G., & Alves, G. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.014 · Cited by 330
Self-citationHallucinations in Parkinson disease
Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.62 · Cited by 312
Self-citationWilliams, D. R., & Lees, A. J. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70146-0 · Cited by 300
Scales to assess psychosis in Parkinson's disease: Critique and recommendations
Fernandez, H. H., Aarsland, D., Fénelon, G., Friedman, J. H., Marsh, L., Tröster, A. I., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., et al. (2008) · Movement Disorders · doi:10.1002/mds.21875 · Cited by 188
Self-citationOphthalmological features of Parkinson disease
Safranow, K. (2014) · Medical Science Monitor · doi:10.12659/msm.890861 · Cited by 119
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms
Pagonabarraga, J., Bejr-Kasem, H., Martinez-Horta, S., & Kulisevsky, J. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00918-8 · Cited by 69
A review of adverse events linked to dopamine agonists in the treatment of Parkinson’s disease
Ceravolo, R., Rossi, C., Del Prete, E., & Bonuccelli, U. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1130128 · Cited by 44
Onofrj, M., Thomas, A., & Bonanni, L. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.12.1731 · Cited by 41
Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction
Ignatavicius, A., Matar, E., & Lewis, S. J. G. (2025) · Brain · doi:10.1093/brain/awae289 · Cited by 32
Stampacchia, S., Bernasconi, F., Van De Ville, D., Amico, E., Pagonabarraga, J., Kulisevsky, J., & Blanke, O. (2025) · doi:10.1101/2025.04.17.649310 · Cited by 5
“…so-called ‘ minor ’ hallucinations (MH) – including presence hallucinations, passage hallucinations, and pareidolias 28,29 – are of clinical relevance, because they often occur at earlier stages of PD 11,30 , may even precede parkinsonian motor symptoms 31 and occur in up to 40% of patients 9,32 .”
Metadata
- Authors
- Doé de Maindreville, A., Fénelon, G., & Mahieux, F.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2004-08-31
- Volume
- 20
- Issue
- 2
- Pages
- 212-217
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2094914578
- Cited by
- 118
- References
- 0
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.